🇺🇸 FDA
Patent

US 8349848

Pyrrolo[3,2-D]pyrimidines that are selective antagonists of A2B adenosine receptors

granted A61PA61P11/06A61P11/08

Quick answer

US patent 8349848 (Pyrrolo[3,2-D]pyrimidines that are selective antagonists of A2B adenosine receptors) held by Dogwood Pharmaceuticals, Inc. expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Dogwood Pharmaceuticals, Inc.
Grant date
Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P11/06, A61P11/08, A61P19/02, A61P3/00